Oct 02, 2019
Blue Cross and Blue Shield Federal Employee Program (FEP) Expands Benefits and Services in 2020
Jun 19, 2019
PBMs Advocate on behalf of Consumers to Reduce Prescription Drug Costs
Apr 08, 2019
PCMA Submits Comments on the Administration's Proposed Rule Revising the Safe Harbors for Prescription Drug Rebates
Jan 31, 2019
PCMA Statement on the Administration's Prescription Drug Rebate Proposed Rule
Jan 02, 2019
PCMA Welcomes New Appointments, Announces New Roles
Nov 26, 2018
PCMA Statement on the Administration's Proposed Medicare Part D Rule
Oct 25, 2018
PCMA Statement on the Administration's Proposed Medicare Part B Pricing Model
Oct 24, 2018
PCMA Applauds the Administration for Enacting Legislation to Curb America's Opioid Crisis
Oct 10, 2018
PCMA Applauds the Administration for Enacting Legislation to Ensure Patients Pay the Lowest Price for Prescription Drugs
Aug 15, 2018
New Data: Rebates are Unrelated to Drugmakers' Pricing Strategies
Jul 16, 2018
New Research: Eliminating Drugmaker Rebates Leads to Significantly Higher Medicare Part D Premiums for Seniors
Apr 03, 2018
PCMA: Trump Administration Does Not Adopt Drugmakers' Proposal to Mandate Point-of-Sale Rebates in Medicare Part D
Jan 04, 2018
Gleostine Price Hike Undercuts Drugmakers' Campaign to Deflect Blame for High Prices
Nov 30, 2017
New Drugmaker Lobby Report Attempts to Deflect Blame for Higher Prices
Nov 17, 2017
PCMA Statement on the CMS Medicare Part D Proposed Rule
Jun 12, 2017
PCMA: Supreme Court Ruling on Biosimilars to Increase Competition, Reduce Drug Costs